Physician profile
Ali N Rizvi
NPI 1811959125
$21,719.29
in general payments reported to CMS, 2019-2025
59 companies · $2,048 in 2025
The $2,048 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $2,074 · 2020: $2,014 · 2021: $1,300 · 2022: $2,336 · 2023: $8,188 · 2024: $3,760 · 2025: $2,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,158 · Travel and Lodging: $6,837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,157.67 |
| Travel and Lodging | $6,837.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,046.52 | 2022-2025 | Resolute Onyx, Turbohawk, Hawkone |
| Abbott Laboratories | $3,131.57 | 2019-2025 | Confirm Rx, Ensite, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,490.99 | 2019-2025 | |
| Boston Scientific Corporation | $860.69 | 2019-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Medtronic Vascular, INC. | $738.04 | 2019-2020 | |
| Amgen INC. | $724.48 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $499.75 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $435.66 | 2019-2023 | Xarelto |
| Shockwave Medical, INC | $429.73 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $385.61 | 2021-2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $350.66 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Avinger INC. | $288.55 | 2020-2023 | Pantheris |
| Abiomed | $287.79 | 2023-2024 | Impella |
| Pfizer INC. | $263.78 | 2019-2022 | |
| Heartflow, INC. | $199.39 | 2019-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $196.10 | 2020-2022 | |
| Esperion Therapeutics, INC. | $177.15 | 2020-2022 | |
| Cvrx, INC. | $175.54 | 2019-2024 | Barostim Neo System |
| Atricure, INC. | $172.22 | 2024-2025 | Synergy Ablation System |
| Baxter Healthcare | $146.46 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Coseal |
| Vifor Pharma, INC. | $138.07 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $128.64 | 2019 | |
| Biotronik INC. | $108.86 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $102.89 | 2019-2021 | |
| Smith+Nephew, INC. | $93.61 | 2022-2025 | Stravix, Renasys Touch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.70 | 2022-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $77.17 | 2019-2024 | Evkeeza, Praluent |
| Kestra Medical Technology Services, INC. | $72.61 | 2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $69.15 | 2019 | |
| Imperative Care, INC | $67.31 | 2024 | Prodigy Catheter |
| Endologix LLC | $55.45 | 2025 | Endocross Device, Torus Stent Graft System |
| Ge Healthcare | $51.49 | 2019-2023 | |
| Elutia, INC. | $46.73 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.45 | 2022-2023 | Verquvo |
| Biosense Webster, INC. | $45.94 | 2019 | |
| Innovation Technologies INC | $43.90 | 2024 | Irrisept |
| Davol INC. | $42.69 | 2022 | |
| Tactile Systems Technology INC | $42.21 | 2019-2022 | |
| Astellas Pharma US INC | $40.52 | 2019 | |
| Edwards Lifesciences Corporation | $28.01 | 2024 | Mitris Resilia Mitral Valve |
| Cardiva Medical, INC. | $25.04 | 2022 | |
| Lemaitre Vascular, INC. | $24.53 | 2025 | Artegraft Vascular Graft |
| Novo Nordisk INC | $23.67 | 2021 | |
| Bardy Diagnostics, INC. | $20.00 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $18.56 | 2019 | |
| Polynovo North America LLC | $18.55 | 2023 | |
| W. L. Gore & Associates, INC. | $18.50 | 2024 | Gore Cardioform Septal Occluder |
| Inspire Medical Systems, INC. | $18.27 | 2025 | Inspire |
| Genzyme Corporation | $18.13 | 2025 | |
| Biotissue Holdings INC. | $18.07 | 2024 | |
| Daiichi Sankyo INC. | $16.14 | 2024 | Injectafer |
| Irhythm Technologies, INC. | $16.08 | 2024 | Zio Xt Patch, Zio Monitor |
| Zoll Circulation INC | $15.50 | 2020 | |
| Cook Medical LLC | $14.68 | 2021 | |
| G Medical Diagnostic Services, INC. | $14.30 | 2022 | |
| Biocompatibles, INC. | $14.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.06 | 2020 | |
| Preventice Services, LLC | $13.30 | 2019 | |
| Allergan, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$97.42 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.